Hebei Lansheng Biotech Co., Ltd.

Xingbai Group - the leading player in the industry of avermectin and emamectin benzoateqrcode

Feb. 23, 2021

Favorites Print
Forward
Feb. 23, 2021

QQ截图20210210103010.png


  • Xingbai Group is an old-line manufacturer of avermectin and emamectin benzoate. How’s the current status of these two products on the market and your future plan for them.


Hebei Xingbai Agricultural Technology Co., Ltd. (Xingbai AgTech for short) is located in Nanbaishe Bio-industrial Park, Zhaoxian County, Hebei Province. Backed by Hebei Xingbai Pharmaceutical Group Co., Ltd. (Xingbai Group for short), Xingbai AgTech produces and sells technical materials (TCs), formulations and intermediates of pesticides, medicines and veterinary drugs, with a market share of around 35% in terms of abamectin and emamectin benzoate TCs. Avermectin (produced by fermentation process) and its derivatives, emamectin benzoate, ivermectin and Abamectin B2, are the fundamental products of Xingbai AgTech. Xingbai Group owns a proprietary production process and extraction technology of abamectin and emamectin benzoate, six patents and the naming right of Abamectin B2. Xingbai Group is the winner of many provincial science and technology awards. In 2016, the project titled Efficient Microbial Synthesis and Biological Production of Avermectin of Xingbai Group won the second prize of National Science and Technology Progress Award. Leaders from the Ministry of Agriculture and Rural Affairs, National Institutes for Food and Drug Control, and Agriculture Department of Hebei Province gave positive comments on the avermectin industry and circular agriculture of Xingbai AgTech, and visited the company for many times, which further inspires the development of the company.


On September 18, 2020, the project titled Safety Assessment of Harmless Treatment and Fertilizer Conversion of Avermectin Residues of Xingbai AgTech passed the national acceptance. It is concluded that the “hot hydrolysis + aerobic compost-fermentation” process is feasible for the compound process of harmless treatment and fertilizer conversion of avermectin residues, and the organic fertilizer produced by this process with avermectin residues has high safety in use. This project lays a foundation for efficient recycling and long-term development of avermectin industry related resources.


This year, Xingbai AgTech ranked 25th among the Top100 Chinese Pesticide Companies by Sales with a revenue of RMB1.963 billion. Xingbai Group owns the State Key Laboratory of Avermectin. In April 2019, Xingbai Group successfully hosted the “Second Conference of Avermectin Alliance for Industry-Enterprise Collaborative Innovations” jointly with the State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology. Xingbai Group is capable of producing 1700 tons of avermectin (converted to 100% concentration). In response to the increasing global demand for emamectin benzoate, we are planning to expand the production capacity of emamectin benzoate by 10%-15% every year to meet the market demand.


QQ截图20210210103210.png

The office building of Xingbai Group


  • At present, there are many players in the industry of avermectin and emamectin benzoate. What’s the competitive advantages of Xingbai Group? 


Avermectin and its derivative emamectin benzoate belong to fermentation biological pesticides, with broad control spectrum, high efficacy, good environmental friendliness and important position in the global plant protection system. Considering the increasing requirement for green development in the world and the rising demand every year, it is no doubt the production capacity expansion conforms to the law of market development. The global production capacity of these products can basically meet the demand, and there is no surplus production capacity. Besides, such capacity is mainly attributable to China, and avermectin is also a product where China has a bigger voice. In 2020, avermectin strains and their production technology were included by the government in the Catalogue of Technologies Prohibited and Restricted from Export. After years of intensive competition, some domestic companies became more stronger on strength of their respective avermectin strains and technologies. These companies have their individual strengths and take different market shares. There is an industrial organization, i.e., Avermectin Product Collaboration Group under CCPIA, which serves to ensure timely communication and negotiation as well as equal competition and cooperation, to guarantee a stable and healthy development of the industry.


Xingbai Group is the only firm in China that produces avermectin with corn as raw material from the very beginning. The company possesses a complete upstream and downstream industrial chain and all necessary technologies, and has cost advantages over the whole industrial chain. After years of high-throughput strain screening, the fermentation titer of Xingbai Group has captured a leading position in the industry. The company focuses on avermectin R&D and holds many technical patents. The State Key Laboratory of Avermectin owned by the company brings together experts and scholars from all over the world for exchange, research, and innovation, and has realized new achievements from the technical technology to formulation one after another. At present, the company holds a variety of formulation technologies and products for controlling mites, insects and nematodes on major food crops and some industrial crops in the world, which help efficiently solve the problems of crop protection in an environmentally friendly way. The company has reached high standards in safety and environmental protection, with stable production, products and quality. The company also provides prompt technical services to solve the problems facing downstream customers in production and use.


QQ截图20210210103316.png    

The R&D and production facility of Xingbai


At present, Xingbai brands are registered in more than 180 countries around the world. Our 36 new compounds have passed the examination process for registration and production qualification by the Ministry of Agriculture and Rural Affairs, and been granted with the production licenses. These efforts will end up solidifying our product portfolio, further supporting and expanding the presence of avermectin and emamectin benzoate, and serving agriculture in a wider market. We will continue the strategy of international registration and simultaneous development of domestic and international markets to secure a stable growth.


QQ截图20210210103404.png  

Xingbai cooperate with overseas customers


  • What efforts and achievements has Xingbai Group made in developing green pesticides and solving farmers' specific problems?


In terms of the production process of technicals, we have always maintained a professional, dedicated and attentive attitude. After years of development and continuous innovation, we have achieved the purified content of avermectin over 98%, and emamectin benzoate over 95%. In 2016, “Efficient Microbial Synthesis and Biological Production of Avermectin” of Xingbai Group won the second prize of National Science and Technology Progress Award. In terms of formulation development, Xingbai Group focuses on research, development, efficacy, formula, etc., and has made differentiated formulas for different crops and pests to meet different needs of users, which has been highly recognized. We keep close cooperation with the CAAS Institute of Plant Protection, Professional Committee of Plant Pathogenic Nematodes, National Agricultural Technology Extension and Service Center, foreign customers and agricultural peers from Southeast Asia, South America and Africa, to test the product formula, and have obtained abundant data. We actively promote green technology, research and develop environmentally friendly adjuvant, and so on. We successfully discovered and extracted the B2 component of avermectin, with which we have the naming right.


Nematode control is a generally difficult problem in the world, and the global annual loss is as high as US$150 million. As a new avermectin product, Avermectin B2 is an excellent insecticide. Avermectin B2 is different from B1 in insecticidal spectrum. It has high activity against root-knot nematodes, root-rot nematodes, cyst nematodes, stem nematodes, pine wood nematodes, etc, and has a good control effect on animal surface pests. On July 29, 2013, the B2 component of avermectin was officially named by the National Technical Committee 133 on Pesticides of Standardization Administration of China as “阿维菌素B2” in Chinese (Avermectin B2 in English). Through extensive lab activity determination experiments and field trials, scientific data so obtained show that Avermectin B2 has high activity on infectious nematodes such as root-knot nematodes, root-rot nematodes, cyst nematodes and stem nematodes of crops such as cucumber, tomato, watermelon, banana, ginger, citrus, sweet potato, Panax notoginseng, Panax quinquefolius, soybean, rice, wheat, etc., with low toxicity, higher safety in use and environmentally friendliness, and good social and economic value.


  • It is reported that Xingbai Group has invested a 1,600t/a emamectin benzoate plant, and has also planned to build another plant. Could you introduce your plan for your products?


Xingbai Group is currently located in Nanbaishe Bio-industrial Park, a part of a provincial economic and technological development zone at Zhao County, Shijiazhuang. The products of Xingbai Group mainly include pesticides and veterinary drugs such as avermectin and its derivatives, spinosad and ivermectin, as well as biological intermediates such as starch and vegetable oil. For further development, Xingbai Group is launching another facility in the Lingang Economic and Technological Development Zone, a national chemical industry park in Cangzhou, to boost the production capacity of 36 technical products such as flonicamid, dinotefuran, cyazofamid, florasulam and bifenazate, so as to seize more international market share. This facility serves to broaden and expand our product line, and gain the economy of scale. The production facilities located in the two parks can complement each other, and the total output value is expected to reach RMB 10 billion in the coming 3-5 years.

The production capacity of emamectin benzoate needs to be determined through industry consultation according to market and industry demand, and scientific planning should be carried out to avoid waste and ensure the healthy and stable development of upstream and downstream industries.


  •  Please talk about the development vision of Xingbai Group.


Since its establishment in 1987, Xingbai Group has been focusing on health industry for 33 years. While focusing on avermectin and emamectin benzoate, we always attach great importance to market demand and actively develop other green, environmentally-friendly and efficient pesticides. On the premise of ensuring safety, environmental protection, quality and efficiency, we serve agriculture and customers at home and abroad. We strive to achieve sales of RMB10 billion in the 14th Five-Year Plan, and make our contribution to creating a healthy future for mankind.


Contact

Email: foreigntrade07@xingbai.net
Tel: +86 13231103681
Web: www.xingbai.cn



This article was initially published in AgroPages ‘2021 China Pesticide Suppliers Guide’ magazine. Download it to read more articles.

QQ截图20210225143319.png




Source: AgroNews

Picture 0/1200

More from AgroNews

Magazine

2021 Certified Organic Agri-inputs Guide Chinese issue of Annual Review 2020
Annual Review 2020 2020 India Pesticide Suppliers Guide
2020 Market Insight Chinese issue of 2020 Market Insight
I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

Picture 0/1200

Subscribe to daily email alerts of AgroNews.